Results 201 to 210 of about 93,200 (346)

Efficacy and Safety of Oral Icotrokinra in Moderate‐to‐Severe Plaque Psoriasis: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis

International Journal of Dermatology, EarlyView.
Meta‐analysis of randomized controlled trials demonstrates that oral icotrokinra significantly improves PASI responses in patients with moderate‐to‐severe plaque psoriasis, with early clinical benefit and a placebo‐comparable safety profile, supported by trial sequential analysis confirming robust and sufficient evidence.
Alhasan Altayf, Munder Lateiresh, Lutfiyah Marwan, Mohamed Yaseen Alfeetouri, Yassine Zouaoui, Muhammed Elhadi   +5 more
wiley   +1 more source

Psoriatic Arthritis: From Diagnosis to Treatment. [PDF]

J Clin Med
Kannappan R, Kim S, Lau A, Brent LH.
europepmc   +1 more source

Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis)

, 2019
Е. Е. Gubar, Е. Yu. Loginova, Т. В. Коротаева, С. И. Глухова, Е. Л. Насонов   +4 more
openalex   +2 more sources

Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In this Phase 3 trial of Japanese patients with moderate to severe PPP (NCT05174065), significantly more patients achieved PPPASI‐50 at Week 16 with apremilast versus placebo. Patient‐reported outcomes, including pruritus and pain/discomfort, also showed significantly greater decreases at Week 16 with apremilast versus placebo.
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Bruce Strober, Melinda Gooderham, Wendy Zhang, Junichiro Shimauchi, Masafumi Yaguchi, Takeshi Kimura, Ryuichi Ogawa, Hamid Amouzadeh, Masamoto Murakami   +15 more
wiley   +1 more source

Psoriasis to psoriatic arthritis in terms of complement proteins: A single center experience. [PDF]

Medicine (Baltimore)
Er E, Cilesizoglu Yavuz N, Sari IF, Kulakli F, Kulakli S.   +4 more
europepmc   +1 more source

Spironolactone in psoriatic arthritis; safety, efficacy and effect on disease activity

, 2014
Ashit Syngle, Inderjeet Verma, Pawan Krishan   +2 more
openalex   +1 more source

POTENTIALS OF MODERN ULTRASOUND TECHNIQUES IN THE DIAGNOSIS OF PSORIATIC ARTHRITIS

, 2021
Yu. Yu. Liashko
openalex   +2 more sources

Impact of weight‐loss interventions on psoriasis severity: A systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Weight‐loss interventions were associated with clinically and statistically significant improvements in psoriasis severity (PASI and PASI 75) and quality of life (DLQI). These findings support the role of weight‐loss interventions as effective adjuncts to medical therapy and their integration into holistic psoriasis care.
Sarah Morrow, Poppy Hawkins, Christopher E. M. Griffiths, Thanasis G. Tektonidis, Eli Harriss, Jadine Scragg, Susan Jebb   +6 more
wiley   +1 more source

Prevalence and predictors of kinesiophobia in psoriatic arthritis: the role of central sensitization and comorbidities. [PDF]

Front Med (Lausanne)
Llamas-Ramos R, Llamas-Ramos I, Alvarado-Omenat JJ, Toledano E, Queiró R, Fernández-Gómez MJ, Martín-Vallejo J, Chacón CC, Díaz-Peña R, Martín D, Hidalgo C, Sánchez MD, Montilla C.   +12 more
europepmc   +1 more source

The Management of Psoriatic Arthritis in Italy: Organizational Impact Analysis of Optimized Pathwaystimized pathways

, 2019
Umberto Restelli, Carlo Selmi, Valeria Pacelli, Davide Croce, Antonio Costanzo   +4 more
openalex   +2 more sources